Westside Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $169K | Hold |
5,000
| – | – | 0.02% | 334 |
|
|
2026
Q1 | $151K | Hold |
5,000
| – | – | 0.02% | 334 |
|
|
2025
Q4 | $156K | Hold |
5,000
| – | – | 0.03% | 315 |
|
|
2025
Q3 | $101K | Hold |
5,000
| – | – | 0.02% | 398 |
|
|
2025
Q2 | $83.8K | Hold |
5,000
| – | – | 0.02% | 366 |
|
|
2025
Q1 | $76.8K | Hold |
5,000
| – | – | 0.02% | 343 |
|
|
2024
Q4 | $110K | Hold |
5,000
| – | – | 0.02% | 299 |
|
|
2024
Q3 | $81.3K | Sell |
5,000
-235
| -4% | -$4.11K | 0.02% | 337 |
|
|
2024
Q2 | $74.4K | Hold |
5,235
| – | – | 0.02% | 334 |
|
|
2024
Q1 | $73.9K | Buy |
5,235
+235
| +5% | +$2.96K | 0.02% | 328 |
|
|
2023
Q4 | $52.2K | Sell |
5,000
-500
| -9% | -$4.67K | 0.01% | 355 |
|
|
2023
Q3 | $56.1K | Hold |
5,500
| – | – | 0.02% | 326 |
|
|
2023
Q2 | $41.4K | Sell |
5,500
-1,000
| -15% | -$8.11K | 0.01% | 380 |
|
|
2023
Q1 | $58.9K | Hold |
6,500
| – | – | 0.02% | 338 |
|
|
2022
Q4 | $45.6K | Hold |
6,500
| – | – | 0.11% | 130 |
|
|
2022
Q3 | $40.4K | Sell |
6,500
-520
| -7% | -$4.6K | 0.1% | 137 |
|
|
2022
Q2 | $42.3K | Hold |
7,020
| – | – | 0.1% | 138 |
|
|
2022
Q1 | $51.7K | Sell |
7,020
-500
| -7% | -$4.17K | 0.11% | 124 |
|
|
2021
Q4 | $44.1K | Hold |
7,520
| – | – | 0.1% | 130 |
|
|
2021
Q3 | $53.6K | Hold |
7,520
| – | – | 0.12% | 117 |
|
|
2021
Q2 | $54.5K | Sell |
7,520
-1,650
| -18% | -$17.5K | 0.13% | 116 |
|
|
2021
Q1 | $75K | Sell |
9,170
-5,300
| -37% | -$60.8K | 0.2% | 91 |
|
|
2020
Q4 | $102K | Sell |
14,470
-150
| -1% | -$1.44K | 0.28% | 66 |
|
|
2020
Q3 | $95.5K | Buy |
14,620
+2,920
| +25% | +$30.9K | 0.04% | 64 |
|
|
2020
Q2 | $118K | Sell |
11,700
-1,000
| -8% | -$11.3K | 0.07% | 47 |
|
|
2020
Q1 | $86.2K | Buy |
+12,700
| New | +$130K | 0.06% | 62 |
|
|
2019
Q2 | $14.6M | Buy |
+5,208
| New | +$62.8K | 5.25% | 2 |
|
|
2018
Q4 | $160K | Sell |
10,124
-230
| -2% | -$4.71K | 0.06% | 171 |
|
|
2018
Q3 | $221K | Sell |
10,354
-1,950
| -16% | -$45.3K | 0.07% | 141 |
|
|
2018
Q2 | $300K | Sell |
12,304
-1,225
| -9% | -$25K | 0.11% | 126 |
|
|
2018
Q1 | $227K | Sell |
13,529
-1,600
| -11% | -$31.2K | 0.12% | 145 |
|
|
2017
Q4 | $289K | Sell |
15,129
-4,425
| -23% | -$66.6K | 0.16% | 129 |
|
|
2017
Q3 | $308K | Sell |
19,554
-11,110
| -36% | -$250K | 0.19% | 109 |
|
|
2017
Q2 | $956K | Sell |
30,664
-2,436
| -7% | -$75.4K | 0.62% | 39 |
|
|
2017
Q1 | $1.06M | Buy |
33,100
+16,430
| +99% | +$561K | 0.51% | 29 |
|
|
2016
Q4 | $573K | Buy |
+16,670
| New | +$666K | 0.39% | 36 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Westside Investment Management's TEVA Position: Q2 2026 in Review
Westside Investment Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 5,000 shares worth $169K. The position accounts for 0.02% of the portfolio, ranked #334.
Westside Investment Management first reported a position in TEVA in Q4 2016 and has held it in 36 quarters since. The position peaked at $14.6M in Q2 2019. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Westside Investment Management held 5,000 shares of Teva Pharmaceuticals worth $169K as of Q2 2026.
- Westside Investment Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
- Teva Pharmaceuticals made up 0.02% of Westside Investment Management's portfolio in Q2 2026, its #334 holding.
- Westside Investment Management first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Teva Pharmaceuticals position peaked at $14.6M in Q2 2019.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.